Clinical Trial Update: Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CHS-1420 to Humira in chronic plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CHS-1420
• Humira (adalimumab)

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-18